Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Smart Biopsy Market, by Application
1.4.2 Europe Smart Biopsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Market Analysis
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Nov – 2016-May) Leading Players
Chapter 4. Europe Smart Biopsy Market by Application
4.1 Europe Breast cancer Market by Country
4.2 Europe Skin cancer Market by Country
4.3 Europe Liver cancer Market by Country
4.4 Europe Prostate cancer Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Smart Biopsy Market by Country
5.1 Germany Smart Biopsy Market
5.1.1 Germany Smart Biopsy Market by Application
5.2 UK Smart Biopsy Market
5.2.1 UK Smart Biopsy Market by Application
5.3 France Smart Biopsy Market
5.3.1 France Smart Biopsy Market by Application
5.4 Russia Smart Biopsy Market
5.4.1 Russia Smart Biopsy Market by Application
5.5 Spain Smart Biopsy Market
5.5.1 Spain Smart Biopsy Market by Application
5.6 Italy Smart Biopsy Market
5.6.1 Italy Smart Biopsy Market by Application
5.7 Rest of Europe Smart Biopsy Market
5.7.1 Rest of Europe Smart Biopsy Market by Application
Chapter 6. Company Profiles
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis